Sol-Gel Technologies (SLGL) Operating Income Growth (5y) (2022 - 2026)
Sol-Gel Technologies (SLGL) Operating Income Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Sol-Gel Technologies | 229.93 Mn | 219.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.81% |
| Dec 31, 2025 | 12.59% |
| Sep 30, 2025 | 6.44% |
| Jun 30, 2025 | 8.26% |
| Mar 31, 2025 | 4.65% |
| Dec 31, 2024 | 32.96% |
| Sep 30, 2024 | -16.08% |
| Jun 30, 2024 | -21.02% |
| Mar 31, 2024 | 1.83% |
| Dec 31, 2023 | -19.59% |
| Sep 30, 2023 | -22.46% |
| Jun 30, 2023 | -23.70% |
| Mar 31, 2023 | 14.01% |
| Dec 31, 2022 | -25.68% |